Clinical Trial Update: Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing Pinverin to reduce bowel FDG uptake in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Pinverin

Snippet

Sponsor: Seoul National University Hospital | Conditions: Cancer | Phase 4 | Status: COMPLETED